These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 29574329

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A new insight into mushroom tyrosinase inhibitors: docking, pharmacophore-based virtual screening, and molecular modeling studies.
    Bagherzadeh K, Shirgahi Talari F, Sharifi A, Ganjali MR, Saboury AA, Amanlou M.
    J Biomol Struct Dyn; 2015; 33(3):487-501. PubMed ID: 24601849
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, computational studies and enzyme inhibitory kinetics of substituted methyl[2-(4-dimethylamino-benzylidene)-hydrazono)-4-oxo-thiazolidin-5-ylidene]acetates as mushroom tyrosinase inhibitors.
    Channar PA, Saeed A, Larik FA, Rafiq M, Ashraf Z, Jabeen F, Fattah TA.
    Bioorg Med Chem; 2017 Nov 01; 25(21):5929-5938. PubMed ID: 28988751
    [Abstract] [Full Text] [Related]

  • 6. A Series of Benzylidenes Linked to Hydrazine-1-carbothioamide as Tyrosinase Inhibitors: Synthesis, Biological Evaluation and Structure-Activity Relationship.
    Hosseinpoor H, Iraji A, Edraki N, Pirhadi S, Attarroshan M, Khoshneviszadeh M, Khoshneviszadeh M.
    Chem Biodivers; 2020 Aug 01; 17(8):e2000285. PubMed ID: 32478439
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tyrosinase inhibitory effects of Vinca major and its secondary metabolites: Enzyme kinetics and in silico inhibition model of the metabolites validated by pharmacophore modelling.
    Sari S, Barut B, Özel A, Şöhretoğlu D.
    Bioorg Chem; 2019 Nov 01; 92():103259. PubMed ID: 31518762
    [Abstract] [Full Text] [Related]

  • 14. Flavonoid derivatives as potent tyrosinase inhibitors - a survey of recent findings between 2008-2013.
    Orhan IE, Khan MT.
    Curr Top Med Chem; 2014 Nov 01; 14(12):1486-93. PubMed ID: 24853561
    [Abstract] [Full Text] [Related]

  • 15. Exploration of Novel Human Tyrosinase Inhibitors by Molecular Modeling, Docking and Simulation Studies.
    Hassan M, Ashraf Z, Abbas Q, Raza H, Seo SY.
    Interdiscip Sci; 2018 Mar 01; 10(1):68-80. PubMed ID: 27098808
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Molecular inhibitory mechanism of dihydromyricetin on mushroom tyrosinase.
    Chen J, Liu S, Huang Z, Huang W, Li Q, Ye Y.
    J Biomol Struct Dyn; 2018 Nov 01; 36(14):3740-3752. PubMed ID: 29067862
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. 3D QSAR pharmacophore-based virtual screening for the identification of potential inhibitors of tyrosinase.
    Ghayas S, Ali Masood M, Parveen R, Aquib M, Farooq MA, Banerjee P, Sambhare S, Bavi R.
    J Biomol Struct Dyn; 2020 Jul 01; 38(10):2916-2927. PubMed ID: 31334690
    [Abstract] [Full Text] [Related]

  • 20. Phosphonic and Phosphinic Acid Derivatives as Novel Tyrosinase Inhibitors: Kinetic Studies and Molecular Docking.
    Wolińska E, Hałdys K, Góra J, Olszewski TK, Boduszek B, Latajka R.
    Chem Biodivers; 2019 Jul 01; 16(7):e1900167. PubMed ID: 31145516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.